Medprin Regenerative Medical Technologies Co. Ltd. (301033) — Financial Flexibility Index
Medprin Regenerative Medical Technologies Co. Ltd. (301033) has a Financial Flexibility Index of 1.50x as of December 2024. Free cash flow of CN¥149.55 Million (operating CF CN¥116.38 Million minus capex CN¥33.16 Million) represents 2% of total liabilities (CN¥99.57 Million). Also explore Medprin Regenerative Medical Technologie (301033) equity growth momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Medprin Regenerative Medical Technologies Co. Ltd. Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Medprin Regenerative Medical Technologies Co. Ltd. across 6 annual periods. Check 301033 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for Medprin Regenerative Medical Technologies Co. Ltd. (2019–2024)
Year-by-year free cash flow to debt coverage for Medprin Regenerative Medical Technologies Co. Ltd.. For the full company profile including market capitalisation, see 301033 stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.50x | CN¥149.55 Million | CN¥116.38 Million | CN¥99.57 Million | ▲ +53.6% |
| 2023 | 0.98x | CN¥147.77 Million | CN¥107.69 Million | CN¥151.11 Million | ▼ -24.5% |
| 2022 | 1.29x | CN¥184.27 Million | CN¥48.31 Million | CN¥142.34 Million | ▲ +0.9% |
| 2021 | 1.28x | CN¥219.22 Million | CN¥66.51 Million | CN¥170.92 Million | ▲ +57.4% |
| 2020 | 0.81x | CN¥95.55 Million | CN¥33.91 Million | CN¥117.26 Million | ▼ -55.3% |
| 2019 | 1.82x | CN¥67.98 Million | CN¥31.27 Million | CN¥37.27 Million | — |